COVID-19 Sample Collection Kits Market Share, Size, Trends, Industry Analysis Report, By Product (Swabs, Viral Transport Media, Blood Collection Kits, Others); By Application (Diagnostics, Research); By Collection Site (Hospitals & Clinics, Home Test), By Regions; Segment Forecast, 2021 - 2028

报告摘要

全球Covid-19样品收集套件市场于2020年估价为128.3亿美元，预计预测期内的CAGr 2.3％。最近Covid-19案件的激增和Covid-19菌株样本的全球必需品是归因于Covid-19样品收集套件市场增长的突出因素。

Collecting samples is the most important and critical step in the effective diagnosis of the COVID-19 strains, as false specimen collection could lead to misleading test results. In line with this, CDC and other concerned healthcare organizations have introduced standard protocols to be followed for collecting samples and streamlining the value chain of COVID-19 related services.

During the ongoing pandemic, with lockdown in place all over the globe, the companies involved in the production of swabs and viral sample collection kits have scaled up their production to cater to the exponential increase in demand.

例如,2020年5月,印度个人衔接giene firm “Suparshva Swabs” announced to scale-up its production of polyester swabs, to be used in sample collecting for COVID-19 testing from 2 to 5 million. According to the company’s claim, it has the largest capacity of cotton buds in whole Asia and can ramp up swab production to more than 30 million in a week. Polyester swabs would cost around INR 3 per unit or less, which is far cheaper than imported swabs.

了解有关此报告的更多信息：request for sample pages

Industry Dynamics

Growth Drivers
Key stakeholders in the COVID-19 sample collection kits market have collaborated with regional manufacturers and suppliers to accelerate the supply of swabs and viral transport media in the global COVID-19 sample kits market. With the ongoing pandemic and surge in demand, companies across the globe are focusing on strategic initiatives to maximize output and supply in the market.

在这方面，在2020年11月，南佛罗里达大学（USF）推出了一种用于商业用途的3D印刷鼻拭子。该组织生产了100,000多个产品，世界各地的医院都使用3D文件来开发数百万拭子以用于PoC测试。

COVID-19 Sample Collection Kits Market Report Scope

该市场主要基于产品，申请，终用和地理区域进行分段。

由产品	通过申请	通过收集网站	按地区
Swabs Nasopharyngeal (NP) swabs Oropharyngeal（op）拭子 鼻拭子 病毒运输媒体 Blood Collection Kits Other Consumables	Diagnostics 研究	医院和诊所 家庭测试	北美（美国，加拿大） 欧洲（法国，德国，英国，意大利，西班牙，荷兰，奥地利） Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea) 拉丁美洲（巴西，墨西哥，阿根廷） 中东和非洲（沙特阿拉伯，阿联酋，以色列，南非）

了解有关此报告的更多信息：request for sample pages

应用洞察力

2020年，诊断市场分部占Covid-19样品收集套件全球市场的最大份额。如此高的份额是由于FDA为Covid-19的诊断测试批准。据估计，在2020年12月，FDA在紧急使用授权下获得了1,295个测试。它包括227个分子试验，61抗体试验，以及7抗原试验，用于诊断Covid-19感染。

However, the research market segment is expected to witness lucrative market growth over the forecast period. This market growth is due to the rise in research and development programs, which deploy sample collection kits to prove the effectiveness of various diagnostic tests. Moreover, extensive research on COVID-19 pathogenesis is further boosted the market segment’s growth prospects.

Insight by Collection Site

2020年，医院和诊所分部占这些样品收集套件的最大收入份额。由于Covid-19由于Covid-19而期间的指数上升主要负责此类市场增长。由于Covid-19案件的全球崛起，大多数医院正在扩大他们对Covid-19诊断的能力。这直接导致通过套件在医院设置中增加了样本收集。

The home test market segment is projected to witness a lucrative growth rate over the forecast period, owing to the high infection rate of the COVID-19 virus and nation-wide lockdown. Recently, in November 2020, Mybiopassport introduced the “COVID-19 & Immunity Profile” test. It is a home-based blood sample collection test. This will help an individual in determining whether he was previously infected with COVID-19 or not.

Geographic Overview

地理位置上，Covid-19样品收集套件的全球市场分叉进入北美，欧洲，亚太地区，拉丁美洲和中东和非洲（MEA）。在北美，美国是最受活跃案件数量最高的最高影响的国家。

据报道，截至2020年12月7日，美国通过套件进行了超过20700万个Covid-19测试，这是所有国家中最高的，其次是欧洲市场。2020年11月，英国政府通过在明年初在全国建立新实验室，计划升高测试能力。这些设施可能会通过这些套件一天处理600,000个PCR测试。

竞争洞察力

Covid-19样品收集套件的全球市场充斥着小型和大型球员。一些主要的参与者在Covid-19样本收集套件中运营的一位关键球员是Lucencess Diagnostics Pte Ltd.，Usiants Holdings，Trinity Biotech，Puritan Medical Products，Danaher Corporation，Becton，Dickinson和Company，Thermo Fisher Scientific，Inc., COPAN Diagnostics, Hardy Diagnostics, Quidel Corporation, Quest Diagnostics, Vitagene Inc., HiMedia Laboratories, and VIRCELL S.L.